Cleared Traditional

K981089 - TISSOMAT AND SPRAY SET

K981089 is an FDA 510(k) clearance for TISSOMAT AND SPRAY SET, manufactured by Baxter Healthcare Corp. The device is a Class 2 General Hospital device with product code FMF cleared through the Traditional 510(k) pathway after a 833-day FDA review.

K981089 · Baxter Healthcare Corp · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2000
Decision
833d
Days
Class 2
Risk

K981089 is an FDA 510(k) clearance for the TISSOMAT AND SPRAY SET. Classified as Syringe, Piston (product code FMF), Class II - Special Controls.

Submitted by Baxter Healthcare Corp (Glendale, US). The FDA issued a Cleared decision on July 5, 2000 after a review of 833 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5860 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General Hospital submissions.

View all Baxter Healthcare Corp devices

FDA 510(k) Submission Details - K981089

510(k) Number K981089 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 25, 1998
Decision Date July 05, 2000
Days to Decision 833 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
704d slower than avg
Panel avg: 129d · This submission: 833d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMF Device Classification - Class 2, Special Controls

Product Code FMF Syringe, Piston
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5860
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMF Syringe, Piston

All 504
Devices cleared under the same product code (FMF) and FDA review panel - the closest regulatory comparables to K981089.
STERILE PISTON SYRINGE
K002717 · Abbott Laboratories · Jan 2001
INJECTRITE-C15 AND INJECTRITE-C30
K002127 · Sterling Medivations, Inc. · Dec 2000
DUPLOGRIP
K003193 · Baxter Healthcare Corp · Nov 2000
TERUMO U-100 INSULIN SYRING
K001474 · Terumo Medical Corp. · Jun 2000
THE WAND
K992404 · Spintech, Inc. · Jun 2000
HAEMACURE HEMAMYST SURGICAL APPLICATOR SYSTEM H-AS01
K994023 · Haemacure Corp. · Apr 2000